These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15153)

  • 1. Effects of bufetolol and propranolol on active and passive membrane properties of dog papillary muscle.
    Inui J; Imamura H
    Jpn J Pharmacol; 1976 Dec; 26(6):639-47. PubMed ID: 15153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptor blocking and electrophysiological effects of bufetolol in the guinea pig atria.
    Inui J; Imamura H
    Eur J Pharmacol; 1977 Feb; 41(3):251-60. PubMed ID: 14011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
    Nakaya H; Kimura S; Nakao Y; Kanno M
    Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers.
    Koerpel BJ; Davis LD
    Circ Res; 1972 Jun; 30(6):681-9. PubMed ID: 5025676
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiological effects of nipradilol (K-351) on isolated rabbit hearts and guinea pig ventricular muscles.
    Kodama I; Anno T; Toyama J; Yamada K
    J Cardiovasc Pharmacol; 1985; 7(6):1013-9. PubMed ID: 2418282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential).
    Coltart DJ; Meldrum SJ
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):188-97. PubMed ID: 4398411
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological studies of celiprolol: III. Effects of celiprolol on the cardiovascular system and renal function, and its antiarrhythmic effects].
    Ochi S; Kimura Y; Matsuzaki T; Hayashi S; Motonaga A; Tanaka M; Fukui H; Yamazaki A; Matsumura K; Miura A
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):209-27. PubMed ID: 1973400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The specificity of action of penbutolol and propranolol and their optical isomers].
    Kaiser J
    Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
    Ono H; Kanazawa Y; O'Hara N; Hashimoto K
    Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
    Evans DB; Peschka MT; Lee RJ; Laffan RJ
    Eur J Pharmacol; 1976 Jan; 35(1):17-27. PubMed ID: 3420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B; Czarnecka M; Lewartowski B
    Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921
    [No Abstract]   [Full Text] [Related]  

  • 13. [Electrophysiological effects of vanilol on isolated papillary muscles of guinea pigs and atrioventricular conduction in rabbits].
    Xiao JG; Li XD; Liu TP
    Zhongguo Yao Li Xue Bao; 1987 Jan; 8(1):40-4. PubMed ID: 2955656
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiologic effects of propranolol on the human heart.
    Prasad K; Kamiyama A; Inoue F
    Jpn Heart J; 1978 Jan; 19(1):136-50. PubMed ID: 650893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of l-penbutolol (Hoe 893d) on the transmembrane potentials of canine purkinje fibers and ventricular muscle fibers.
    Kodama I; Shimizu T; Iwamura N; Hirata Y; Toyama J; Yamada K
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):232-42. PubMed ID: 25633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and interpretation of voltage- and frequency-dependent electrophysiologic effects of a new class I antiarrhythmic agent (nicainoprol) on guinea pig papillary muscle and isolated heart.
    Weirich J; Antoni H
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):664-71. PubMed ID: 2467084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
    Lee RJ; Evans DB; Baky SH; Laffan RJ
    Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carvedilol on atrioventricular conduction in the ischemic heart.
    Horio T; Ito S; Aoyama M; Takeda Y; Suzumura H; Nakata K; Yamada Y; Suzuki S; Fukutomi T; Itoh M
    Eur J Pharmacol; 2001 Jan; 412(2):145-53. PubMed ID: 11165226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a new adrenergic beta receptor blocker ACC-9089 on transmembrane potential of canine Purkinje fibers in comparison with propranolol].
    Tan YH; Wit AL
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):82-7. PubMed ID: 2867664
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.
    Wit AL; Hoffman BF; Rosen MR
    Am Heart J; 1975 Dec; 90(6):795-803. PubMed ID: 903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.